Medicaments containing gelatin cross-linked with oxidized polysaccharides
AssigneeInnogenetics N.V.
InventorsEtienne Schacht, Jean Pierre Draye, Bernard Delaey
Life of this patent
Estimating the term…
Loading patent…
AssigneeInnogenetics N.V.
InventorsEtienne Schacht, Jean Pierre Draye, Bernard Delaey
Estimating the term…
The present invention relates to a wound dressing comprising a biopolymer matrix comprising gelatin cross-linked with an oxidized polysaccharide. Preferably said oxidized polysaccharide comprises an oxidized dextran or an oxidized xanthan. Preferably said matrix is in the form of a hydrated film, a hydrated or dry foam, dry fibers which may be fabricated into a woven or non-woven tissue, hydrated or dry microbeads, dry powder; or said matrix is covered with a semipermeable film, so as to control the humidity of the wound covered with the dressing, with the permeability chosen so as to maintain this humidity within a therapeutically optimal window. A polysulfated polysaccharide with a M.W. greater than 30,000 kDa is mechanically entrapped during the formation of said matrix.
A medicament containing a biopolymer matrix comprising gelatin cross-linked with an oxidized polysaccharide and wherein a polysulfated polysaccharide with a MW greater than 30,000 kDa is mechanically entrapped during the formation of said matrix, thereby forming a semi-interpenetrating polymer network.
Dependencies are inferred from the claim text.